Artwork
iconShare
 
Manage episode 490867525 series 3325113
Content provided by Informa Markets. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Informa Markets or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In a significant industry move this February, Baxter completed the sale of its kidney care business to The Carlyle Group, creating Vantive—a company now experiencing a unique balance of established expertise and newfound agility.

CEO Chris Toth recently shared Vantive's ambitious vision, highlighting the firm's commitment to investing over $1 billion in digitally-enabled kidney care solutions. Toth discussed how this strategic separation has empowered the company to maintain its valuable legacy while gaining the flexibility to execute decisions more rapidly.

During the conversation, Toth also offered personal insights into his role as a medtech CEO and shared his deep passion for Vantive's mission to transform kidney care.

  continue reading

85 episodes